aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
iQure Pharma, founded by entrepreneurs with strong backgrounds in the pharmaceutical and financial industries, focuses on developing innovative therapeutic solutions. The company's core mission is to bridge the gap between academic research and the pharmaceutical industry, translating groundbreaking scientific discoveries into viable medical treatments. iQure Pharma offers a range of products and services centered on novel therapeutics, targeting unmet medical needs in various disease areas.
Notable affiliated individuals include experts from both academia and the pharmaceutical sector, enhancing the company's ability to innovate. Key achievements include successful partnerships with leading research institutions and advancements in their drug development pipeline. iQure Pharma's impact lies in its unique approach to integrating academic research with industry practices, accelerating the development of new treatments and addressing critical health challenges globally.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Therapeutics
Technology
Biotech
Tags
SaaS
Model Types
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was iQure Pharma founded?
iQure Pharma was founded in 2019.
Where is iQure Pharma's headquarters located?
iQure Pharma's headquarters is located in Wilmington, DE, US.
When was iQure Pharma's last funding round?
iQure Pharma's most recent funding round was for $1.2M (USD) in October 2023.
How many employees does iQure Pharma have?
iQure Pharma has 6 employees as of Feb 5, 2024.
How much has iQure Pharma raised to-date?
As of July 05, 2023, iQure Pharma has raised a total of $1.9M (USD) since Oct 11, 2023.
Add Comparison
Total Raised to Date
$1.9M
USD
Last Update Oct 11, 2023
Last Deal Details
$1.2M
USD
Oct 11, 2023
Series Unknown
Total Employees Over Time
6
As of Feb 2024
iQure Pharma Address
Wilmington,
Delaware
19801
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts